You are here

asthma

Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication

Fierce Biotech

Wed, 11/9/22 - 10:43 am

Sanofi, Regeneron team with Broadway actor for digital severe asthma program

Medical Marketing and Media

Wed, 10/19/22 - 10:54 pm

pharma marketing

AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’

Endpoints

Wed, 10/5/22 - 10:35 am

pharma marketing

DTC advertising

eosinophilic asthma

Sanofi’s asthma therapy shows consistent safety profile in Phase III trial

Clinical Trials Arena

Tue, 09/6/22 - 05:06 pm

clinical trials

Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026

BioSpace

Thu, 07/21/22 - 10:24 am

Transpire Bio signs with Recipharm for inhaled medicine development

European Pharmaceutical Review

Tue, 07/19/22 - 10:38 am

drug development

Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review

Fierce Biotech

Tue, 07/19/22 - 10:36 am

Retinitis pigmentosa

Areteia gets $350M to turn failed ALS drug into a therapy for severe asthma

MedCity News

Tue, 07/12/22 - 11:29 pm

Areteia Therapeutics

eosinophilic asthma

Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases

BioSpace

Thu, 06/2/22 - 10:35 am

Masimo's (MASI) PVi Favored by New Study for Pediatric Patients

Yahoo/Zacks.com

Thu, 05/26/22 - 10:13 am

GSK 'schemed' FDA's drug-device approval pathway to deflect asthma inhaler generics, lawsuit claims

Fierce Pharma

Wed, 05/25/22 - 10:30 am

drug-device combos

AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial

Pharmaforum

Mon, 05/16/22 - 10:24 am

clinical trials

calbuterol/budesonide

Teva suffers setback on in-house asthma program as a PhII study is halted early due to futility

Endpoints

Wed, 03/23/22 - 11:06 am

Teva Pharmaceutical

clinical trials

AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire

Fierce Pharma

Thu, 01/6/22 - 11:52 am

Broad Institute

4D Pharma sees positive data from early stage asthma trial

Biopharma Reporter

Wed, 12/22/21 - 11:32 pm

clinical trials

Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort

Fierce Pharma

Tue, 12/14/21 - 11:33 pm

Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most

Stat

Wed, 12/8/21 - 11:45 pm

clinical trial diversity

Aiming to uproot the market for asthma attacks, AstraZeneca and Avillion tout two PhIII wins for inhaled combo drug

Endpoints

Thu, 09/9/21 - 10:58 am

clinical trials

Amgen builds case for severe asthma drug tezepelumab

Pharmaforum

Mon, 09/6/21 - 09:11 pm

AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA

Endpoints

Thu, 07/29/21 - 11:10 am

Pages